Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial.
Bai C, Zheng Y, Sun M, Ying J, Zhou F, Yu Y, Xing L, Zhang Y, Wen J, Wu H, Yang X, Wan L, Guo S, Zhao R, Zhu Z, Shen W, Wang Q, Gu S, Wu H, Chen W, Xia J, Zhao J, Dong X, Lou W, Jiang K, Zhang Z, Chen X, Fu D, Chen Y, Wang B, Liu J, Ji Y, Yuan S, Li Y, Gong Z, Fei D, Qin X, Qin C, Li J.
Bai C, et al. Among authors: guo s.
Eur J Cancer. 2025 Nov 17;230:115808. doi: 10.1016/j.ejca.2025.115808. Epub 2025 Sep 20.
Eur J Cancer. 2025.
PMID: 41005213
Clinical Trial.